Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

VIGEN VICK ABOVIAN

Allopathic & Osteopathic Physicians Family Medicine

NPI
1104135391
CMS profile
321863
Location
GLENDALE, CA

General Payments · PY2018–2024

$2,578.63

  • Reported across 67 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$878.11

14 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $878.11 14

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
ABBVIE INC. $277.82 8
OptiNose US, Inc. $126.86 1
Amgen Inc. $122.12 1
Acerta Pharma LLC $119.83 1
Salix Pharmaceuticals, a division of Bausch Health US, LLC $111.49 1
Ardelyx, Inc. $104.54 1
PFIZER INC. $15.45 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $588.99 23
PY2019 $548.78 18
PY2020 $117.57 1
PY2021 $29.98 2
PY2022 $129.66 2
PY2023 $285.54 7
PY2024 $878.11 14

Payment records · PY2024 (14)

Sorted by paying entity, then date · as published by CMS

Program year 2024 201820192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
ABBVIE INC. $22.57 01/31/2024 Food and Beverage Undisputed 01/23/2026 1103167886 CMS
ABBVIE INC. $32.24 02/29/2024 Food and Beverage Undisputed 01/23/2026 1103167888 CMS
ABBVIE INC. $28.12 03/07/2024 Food and Beverage Undisputed 01/23/2026 1103167890 CMS
ABBVIE INC. $26.30 08/27/2024 Food and Beverage Undisputed 01/23/2026 1103167892 CMS
ABBVIE INC. $25.69 09/19/2024 Food and Beverage Undisputed 01/23/2026 1103167894 CMS
ABBVIE INC. $114.09 09/19/2024 Food and Beverage Undisputed 01/23/2026 1103167896 CMS
ABBVIE INC. $21.70 10/17/2024 Food and Beverage Undisputed 01/23/2026 1103167898 CMS
ABBVIE INC. $7.11 11/11/2024 Food and Beverage Undisputed 01/23/2026 1103167900 CMS
Amgen Inc. $122.12 01/26/2024 Food and Beverage Undisputed 01/23/2026 1115407505 CMS
Ardelyx, Inc. $104.54 09/25/2024 Food and Beverage Undisputed 01/23/2026 1146666677 CMS
AstraZeneca Pharmaceuticals LP $119.83 03/27/2024 Food and Beverage Undisputed 01/23/2026 1104714275 CMS
Optinose US, Inc. $126.86 08/23/2024 Food and Beverage Undisputed 01/23/2026 1142183610 CMS
PFIZER INC. $15.45 04/24/2024 Food and Beverage Undisputed 01/23/2026 1131400872 CMS
Salix Pharmaceuticals, a division of Bausch Health US, LLC $111.49 11/21/2024 Food and Beverage Undisputed 01/23/2026 1153453689 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.